News

2016

company

year

domain

Evelo Biosciences Participates in White House Office of Science and Technology Policy’s National Microbiome Initiative Event

Evelo Biosciences 05.13.2016

Seres Therapeutics Announces Collaboration with University of Pennsylvania Researchers to Support the Development of Microbiome Therapeutics for Rare Genetic Metabolic Diseases and Inflammatory Bowel Disease

Seres Therapeutics 05.12.2016

Seres Therapeutics Announces Broad Agreement with Memorial Sloan Kettering Cancer Center to Develop Microbiome Therapeutics for Hematopoietic Stem Cell Transplantation and Immuno-Oncology Treatment

Seres Therapeutics 05.12.2016

Agios Reports First Quarter 2016 Financial Results

05.05.2016

Acceleron Pharma Reports First Quarter 2016 Financial and Operational Results

Acceleron Pharma 05.05.2016

Editas Medicine Achieves Milestone under its Collaboration with Juno Therapeutics

Editas Medicine 05.04.2016

Seres Therapeutics Announces Academic Collaborations to Support Development of Microbiome Therapeutics for Inflammatory Bowel Disease

Seres Therapeutics 05.04.2016

Seres Therapeutics Announces Achievement of Target Enrollment of SER-109 Phase 2 Study for the Prevention of Recurrent Clostridium difficile Infection

Seres Therapeutics 05.02.2016

Visterra Appoints Two Industry Leaders to its Board of Directors

Visterra 04.21.2016

Syros Pharmaceuticals Presents New Data Demonstrating Significant Anti - Tumor Activity of its Selective CDK7 Inhibitor in Preclinical Models of Acute Myeloid Leukemia

Syros Pharmaceuticals 04.20.2016

Loading